Global Dihydroquercetin Market Strategic Research Report

Scope of the Report

The global Dihydroquercetin market size is predicted to grow from US$ 35.07 million in 2025 to US$ 51.35 million in 2032; it is expected to grow at a CAGR of 5.7% from 2026 to 2032.

Dihydroquercetin, also known as taxifolin, taxifolin, and cedarwood, is a chemical substance extracted from pine plants such as larch and Douglas-fir. It belongs to the flavonoid class. Dihydroquercetin appears as fine crystalline particles or an amorphous, pale yellow powder with a slightly bitter taste. Global dihydroquercetin sales are expected to reach 20,000 kilograms in 2024, with an average selling price of US$1,500 per kilogram. The industry's gross profit margin is approximately 40%-50%.

Upstream: Raw materials rely on plants such as larch, and supply is subject to geographical and seasonal constraints, necessitating the establishment of stable supply channels. Midstream: Continuous innovation in production processes and extraction technologies, such as metabolic engineering of brewer's yeast production, is underway to increase yield and purity. Downstream: Applications are expanding from pharmaceuticals to food and cosmetics, and market demand continues to grow. Companies need to strengthen supply chain collaboration, optimize production processes, and expand sales channels to cope with raw material fluctuations and market competition.

Core global dihydroquercetin manufacturers include Ametis JSC, ROBIOS LLC, Taxifolia, Jilin Jianwei Natural Biotechnology Co., Ltd., and Changsha Jincao Biotechnology Co., Ltd. The top three manufacturers hold approximately 82% of the global market share. Europe is the largest market, accounting for approximately 42% of the market share, followed by North America and Asia Pacific, with 30% and 24%, respectively.

Market drivers include the following:

Increasing health awareness: Consumer demand for natural and functional ingredients is driving the growth of the health supplement and functional food markets. Dihydroquercetin, a powerful antioxidant, can delay aging and enhance immunity, aligning with consumers' pursuit of health management.

Aging and chronic diseases: Global aging is accelerating, and the incidence of chronic diseases such as cardiovascular disease and diabetes is rising. Dihydroquercetin has cholesterol-lowering, anti-platelet aggregation, and anti-inflammatory effects, making it an adjunct treatment for chronic diseases, leading to continued market demand.

Regulatory support and technological innovation: Domestic and international regulations have approved dihydroquercetin for use in food and pharmaceuticals, providing regulatory compliance assurance. Furthermore, advances in extraction technology are reducing production costs, improving product quality, and enhancing market competitiveness, driving large-scale development in the industry.

This report presents a comprehensive overview of the global Dihydroquercetin market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Product Form

• Purity below 95%
• Purity above 95%

Segment by Application

• Pharmaceutical Industry
• Food Industry
• Cosmetics Industry
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Dihydroquercetin market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Pharmaceutical Industry, Food Industry, Cosmetics Industry evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact